
Actithera: Radiopharma Funding Gathers Huge Momentum
Actithera, a radiopharmaceutical biotechnology company translating principles of medicinal chemistry into the next generation of radioligand therapies (RLTs), today announced the successful closing of an oversubscribed Series A financing round totaling US …